In a regulatory filing, GoodRx Holdings disclosed that on January 16, the company determined that the role currently held by Raj Beri, the company’s Chief Operating Officer, will be eliminated and the company’s board of directors removed Mr. Beri as Chief Operating Officer, effective as of February 15. “Mr. Beri is expected to remain Chief Operating Officer of the company through the Effective Date to assist with the transition of his duties, and thereafter separate from the company,” the filing stated.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on GDRX:
- GoodRx price target raised to $7 from $5 at RBC Capital
- GoodRx price target raised to $7.50 from $5.50 at Truist
- GoodRx Stock (NASDAQ:GDRX) Gained on Upbeat Q4 Preliminary Results
- GoodRx pre-announcement ‘directionally positive,’ says Wells Fargo
- GoodRx sees FY23 revenue $749M-$751M, consensus $744.26M